BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9358661)

  • 1. Is haemorrhagic myocardial infarction more common with streptokinase?
    Naik AM; Nabar AA; Lokhandwala YY; Kulkarni HL; Deshpande JR; Sivaraman A
    Indian Heart J; 1997; 49(4):387-90. PubMed ID: 9358661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early cardiac rupture following streptokinase in patients with acute myocardial infarction: retrospective cohort study.
    Polić S; Perković D; Stula I; Punda A; Lukin A; Rumboldt Z
    Croat Med J; 2000 Sep; 41(3):303-5. PubMed ID: 10962050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotension in acute myocardial infarction patients given streptokinase.
    Lateef F; Anantharaman V
    Singapore Med J; 2000 Apr; 41(4):172-6. PubMed ID: 11063182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical development of the in-hospital phase of acute myocardial infarction in patients treated with intravenous streptokinase].
    Frutos E; Verdejo J; Morales E; Martínez-Ríos MA; Cárdenas M
    Arch Inst Cardiol Mex; 1990; 60(3):289-93. PubMed ID: 2241403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid infusion of streptokinase standard dose in acute myocardial infarction is followed by a higher rate of coronary reperfusion than standard protocol.
    Tatu-Chiţoiu G; Orha I; Teodorescu C; Flueraşu A; Serban L; Bumbu A
    Rom J Intern Med; 1997; 35(1-4):47-54. PubMed ID: 9562652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does reperfusion modify the risk of heart rupture? Effects of early reperfusion].
    Cortadellas J; Figueras J
    Rev Esp Cardiol; 1992; 45 Suppl 2():66-71. PubMed ID: 1475511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
    Teslia AN; Kolesnikov SA; Mikhaĭlov AA
    Voen Med Zh; 1999 Jul; 320(7):40-4. PubMed ID: 10484919
    [No Abstract]   [Full Text] [Related]  

  • 10. Multicenter clinical trial using an accelerated streptokinase regimen in patients with acute myocardial infarction.
    Xu C; Zhang T
    Chin Med J (Engl); 2000 Aug; 113(8):733-6. PubMed ID: 11776059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study).
    Tatu-Chitoiu G; Teodorescu C; Capraru P; Guran M; Istratescu O; Dan M; Tatu-Chitoiu A; Bumbu A; Chioncel V; Dorobantu M
    Kardiol Pol; 2004 May; 60(5):441-6. PubMed ID: 15247958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does intravenous streptokinase therapy facilitate the formation of anti-heart antibodies in acute myocardial infarction?
    Scolozzi R; Boccafogli A; Vicentini L; Masotti M; Baraldi A; Pradella A; Baggioni GF; Camerani A; Boniotti A
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):297-300. PubMed ID: 2640051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of rapid infusion of streptokinase in patients with acute myocardial infarction.
    Srimahachota S; Sangwatanaroj S; Boonyaratavej S; Suitichaiyakul T; Ngarmukos P
    J Med Assoc Thai; 2000 Jan; 83(1):8-12. PubMed ID: 10710863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of streptokinase for acute cerebral infarction.
    Morris AD; Ritchie C; Grosset DG; Adams FG; Lees KR
    QJM; 1995 Oct; 88(10):727-31. PubMed ID: 7493170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse pulmonary hemorrhage after streptokinase administration for acute myocardial infarction.
    Swanson GA; Kaeley G; Geraci SA
    Pharmacotherapy; 1997; 17(2):390-4. PubMed ID: 9085336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eligibility of patients with acute myocardial infarction for thrombolytic therapy: retrospective cohort study.
    Zaputović L; Mavrić Z; Mlinarić B; Kupanovac Z; Matana A; Marinović D
    Croat Med J; 2000 Dec; 41(4):401-5. PubMed ID: 11063763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.